Actively Recruiting
Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease
Led by Al-Azhar University · Updated on 2025-11-18
60
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to Evaluation of Therapeutic Plasma Exchange for Immune-Mediated Neurological Diseases in a Sample of Egyptian Patients: An Experience at Al-Azhar University Hospitals, including evaluating clinical response rates and functional improvement.
CONDITIONS
Official Title
Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All neurological patients of any age undergoing therapeutic plasma exchange
- New or relapse cases meeting ASFA guidelines where plasma exchange is first or second line therapy
You will not qualify if you...
- Individuals with contraindications to therapeutic plasma exchange such as hemodynamic instability, hypocalcaemia, or allergy to plasma or albumin
- Patients undergoing fewer than five cycles of plasma exchange who do not complete the procedure
- Patients with non-neurological disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Al-Azhar University Hospitals
Cairo, Egypt
Actively Recruiting
Research Team
W
Wajdi Hamid Eisay, MD
CONTACT
H
Hussein Mohammed Hussein, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here